Multifactorial Approach to Predicting Resistance to Anthracyclines

2011187 citationsJournal Article

Authors

Christine Desmedt · Hôpitaux Iris Sud

Angelo Di Leo · Hôpitaux Iris Sud

Evandro de Azambuja · Hôpitaux Iris Sud

Denis Larsimont · Hôpitaux Iris Sud

Benjamin Haibe‐Kains · Hôpitaux Iris Sud

J. Selleslags · Hôpitaux Iris Sud

Suzette Delaloge ·

Abstract

Given its high NPV, the A-Score could become, if further validated, a useful clinical tool to identify those patients who do not benefit from anthracyclines and could therefore be spared the non-negligible adverse effects.

Topics & Keywords

Breast Cancer Treatment Studies Advanced Biosensing Techniques and Applications HER2/EGFR in Cancer Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 29, Issue 12, pp. 1578-1586

DOI: 10.1200/jco.2010.31.2231

Field-Weighted Citation Impact: 10.06